Accelerated Enrollment Solutions Launches Patient-Transfer Program to Support Trial Continuity During COVID-19 Pandemic


Applied Clinical Trials

Accelerated Enrollment Solutions (AES) has launched a program to help biopharmaceutical companies maintain business continuity during the global COVID-19 pandemicby transferring clinical trial patients to AES’ dedicated research sites from other research facilities.


To find out more, click here.

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.